IRL-2500 (S)-2-((R)-3-([1,1'-联苯]-4-基)-2-(N,3,5-三甲基苯甲酰胺基)丙酰胺基)-3-(1H-吲哚-3-基)丙酸
CAS 169545-27-1 MFCD00948945
化学结构图
SMILES: CC1=CC(=CC(C)=C1)C(=O)N(C)[C@H](CC1C=CC(=CC=1)C1C=CC=CC=1)C(=O)N[C@@H](CC1=CNC2C=CC=CC1=2)C(O)=O
化学属性
| Mol. Formula | C36H35N3O4 |
|---|---|
| Mol. Weight | 573.69 |
别名和识别编码
| Chemical Name | IRL-2500 |
|---|---|
| Chemical Name Translation | (S)-2-((R)-3-([1,1'-联苯]-4-基)-2-(N,3,5-三甲基苯甲酰胺基)丙酰胺基)-3-(1H-吲哚-3-基)丙酸 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Webb RL, et al. Effects of the ETB-selective antagonist IRL 2500 in conscious spontaneously hypertensive and Wistar-Kyoto rats.J Cardiovasc Pharmacol. 1995;26 Suppl 3:S389-92.
- [1]. Balwierczak JL, et al. Characterization of a potent and selective endothelin-B receptor antagonist, IRL 2500.J Cardiovasc Pharmacol. 1995;26 Suppl 3:S393-6.
- [1]. Balwierczak JL, et al. Characterization of a potent and selective endothelin-B receptor antagonist, IRL 2500.J Cardiovasc Pharmacol. 1995;26 Suppl 3:S393-6.
- [2]. Webb RL, et al. Effects of the ETB-selective antagonist IRL 2500 in conscious spontaneously hypertensive and Wistar-Kyoto rats.J Cardiovasc Pharmacol. 1995;26 Suppl 3:S389-92.
